This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Technology Limited. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Duncan Christopher Hone: Innovator in Nanoparticle Technology
Introduction
Duncan Christopher Hone is a notable inventor based in Norfolk, GB. He has made significant contributions to the field of nanoparticle technology, particularly in the area of photodynamic therapy.
Latest Patents
Hone holds a patent for "Photosensitizer functionalised nanoparticles." This invention relates to the self-assembly of a photosensitizer on a nanoparticle. The patent also provides methods for the production of functionalized nanoparticles, which may be used in photodynamic therapy (PDT). The invention can produce self-assembled phthalocyanine monolayers (SAMs) formed on metallic nanoparticles. The term 'metallic' refers to metals, metal oxides, and other metal-containing compositions. According to the invention, a functionalized nanoparticle comprises 1 patent.
Career Highlights
Duncan Hone has been associated with Cancer Research Technology Limited, where he has applied his expertise in nanoparticle technology to advance cancer treatment methodologies. His work has the potential to significantly impact the effectiveness of photodynamic therapy.
Collaborations
Hone has collaborated with David Andrew Russell, contributing to the development of innovative solutions in the field of cancer research.
Conclusion
Duncan Christopher Hone is a pioneering inventor whose work in functionalized nanoparticles is paving the way for advancements in photodynamic therapy. His contributions are vital to the ongoing research and development in cancer treatment technologies.